DE NOVO CANCER INCIDENCE IN ELDERLY LIVER TRANSPLANT RECIPIENTS RECEIVING INDUCTION IMMUNOSUPPRESSION

被引：0
|
作者：
Dalbec, Kathryn M. [1 ]
Mangus, Richard S. [1 ]
Fridell, Jonathan A. [1 ]
Vianna, Rodrigo M. [1 ]
Tector, A. Joseph [1 ]
机构：
[1] Indiana Univ, Sch Med, Dept Surg, Transplant Div, Indianapolis, IN 46202 USA
来源：
LIVER TRANSPLANTATION | 2008年 / 14卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [21] FACTORS AFFECTING SURVIVAL OF DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH THYMOGLOBULIN INDUCTION
    Zuckermann, A.
    Pellegrini, C.
    Arizon, J. M.
    Favoloro, R.
    Jiang, H.
    Cornu-Artis, C.
    Lopez, P.
    Wang, S. -S.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 67 - 67
  • [22] SWITCHING LONGTERM RENAL TRANSPLANT RECIPIENTS TO mTOR-BASED IMMUNOSUPPRESSION MAY REDUCE DE NOVO SKIN CANCER INCIDENCE
    Hanel, M. Tufail
    Itin, P.
    Steiger, J.
    Bock, A.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 236 - 236
  • [23] Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review
    Chak, Eric
    Saab, Sammy
    LIVER INTERNATIONAL, 2010, 30 (09) : 1247 - 1258
  • [24] Incidence and Recurrence of Pleural Effusions in De Novo Cardiac Transplant Recipients with MMF vs Everolimus Immunosuppression.
    Ross, Heather
    Lehmkuhl, Hans
    Wang, Shoei-Shen
    Vigano, Mario
    Zuckermann, Andreas
    Varnous, Shaida
    Frigero, Maria
    Laufer, Gunther
    Potena, Luciano
    Keogh, Anne
    Livi, Ugolino
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 652 - 652
  • [25] Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
    Bhat, Mamatha
    Mara, Kristin
    Dierkhising, Ross
    Watt, Kymberly D. S.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (09) : 1236 - 1246
  • [26] TRIPLE THERAPY AND INCIDENCE OF DE-NOVO CANCER IN RENAL-TRANSPLANT RECIPIENTS
    KEHINDE, EO
    PETERMANN, A
    MORGAN, JD
    BUTT, ZA
    DONNELLY, PK
    VEITCH, PS
    BELL, PRF
    BRITISH JOURNAL OF SURGERY, 1994, 81 (07) : 985 - 986
  • [27] An Evaluation of De Novo Sirolimus or Tacrolimus Maintenance Immunosuppression on Renal Function in Orthotopic Liver Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction with a Primary Disease of Hepatitis C.
    Ally, Winston
    Duhart, Benjamin, Jr.
    Krauss, Amy
    Vanatta, Jason
    Mya, Maung
    Nezakatgoo, N.
    Eason, James
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 351 - 351
  • [28] New Onset Diabetes Mellitus in Kidney Transplant Recipients Receiving De Novo Steroid Free Maintenance Immunosuppression.
    Luan, Fu Lung
    Steffick, Diane
    Akinlolu, Ojo O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 208 - 208
  • [29] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
  • [30] De novo breast cancer in renal transplant recipients
    Buell, JF
    Hanaway, MJ
    Trofe, J
    Gross, TG
    Beebe, TM
    Alloway, RR
    First, MR
    Woodle, ES
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1778 - 1779
12345